Section Iv Cancer And Infectious Diseases

Editor: Jacob J. Plattner, Chiron Corp Emeryville, CA

Chapter 17. Progress in Antifungal Drug Discovery

Mark B. Anderson, Terry Roemer, and Robyn Fabrey Elitra Pharmaceuticals 3510 Dunhill Street, San Diego CA 92121

Introduction - The incidence of opportunistic fungal infections such as Aspergillus species, Candida spp. (C. albicans and others) and Cryptococcus neoformans has been increasing worldwide despite active research programs devoted to the discovery and development of novel antifungal agents (1,2). Effectively treating opportunistic fungal infections represents a significant threat to the general human condition, especially those with compromised immune systems brought on by chemotherapy treatment for cancer, organ transplants, surgery, and inflictions with HIV/AIDS or other immune compromising events (3,4). A second growing concern is the incidence of drug resistance of fungal pathogens to the currently known classes of antifungal agents used in the clinic (5,6). These two factors accentuate the urgency for the ongoing rapid identification of exploitable antifungal targets, to develop safer and more effective therapeutic agents, and to discover new chemical entities (NCE) to fight current and drug resistant fungal infections (7). This paper examines a select number of emerging antifungal compounds and captures recent advances in antifungal agents of a known mechanism of action.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment